TSS
CNTX icon

Two Sigma Securities’s Context Therapeutics CNTX Stock Holding History

Two Sigma Securities’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.9K Buy
+12,573
New +$29.4K ﹤0.01% 1313
2023
Q1 		– Sell
-19,350
Closed -$12.6K – 2744
2022
Q4 		$12.6K Sell
19,350
-5,498
-22% -$5.92K ﹤0.01% 2333
2022
Q3 		$28K Buy
+24,848
New +$44.7K ﹤0.01% 2263

Other funds holding CNTX

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Securities's CNTX Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Context Therapeutics (CNTX) in Q1 2026: 12,573 shares worth $32.9K. The stake represents ﹤0.01% of the portfolio and ranks #1313 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CNTX as recently as Q4 2022.

Two Sigma Securities first reported a position in CNTX in Q3 2022 and has held it in 3 quarters since. 59 funds tracked by Wall St. Rank hold CNTX as of Q1 2026.

  • Two Sigma Securities held 12,573 shares of Context Therapeutics worth $32.9K as of Q1 2026.
  • Context Therapeutics was a new Two Sigma Securities position in Q1 2026.
  • Context Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1313 holding.
  • Two Sigma Securities first reported a position in Context Therapeutics in Q3 2022 and has held it in 3 quarters since.
  • 59 funds tracked by Wall St. Rank held Context Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.